Rubinstein Linda M 4
4 · Adverum Biotechnologies, Inc. · Filed Jun 9, 2023
Insider Transaction Report
Form 4
Rubinstein Linda M
CHIEF FINANCIAL OFFICER
Transactions
- Purchase
Common Stock
2023-06-07$1.45/sh+100,000$145,490→ 100,000 total
Footnotes (1)
- [F1]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.38 to $1.53. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.